UBS AM’s Edwards Lifesciences EW Stock Holding History

UBS AM’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$437M	Buy	5,458,148 +74,511	+1%	+$6.14M	0.09%	200
2025 Q4	$459M	Sell	5,383,637 -201,009	-4%	-$16.5M	0.1%	170
2025 Q3	$434M	Buy	5,584,646 +4,108,270	+278%	+$321M	0.09%	190
2025 Q2	$115M	Sell	1,476,376 -5,307,192	-78%	-$396M	0.02%	509
2025 Q1	$492M	Buy	6,783,568 +264,311	+4%	+$18.9M	0.13%	168
2024 Q4	$483M	Buy	6,519,257 +513,468	+9%	+$35.9M	0.11%	163
2024 Q3	$396M	Buy	6,005,789 +61,275	+1%	+$4.45M	0.1%	179
2024 Q2	$549M	Buy	5,944,514 +1,545,063	+35%	+$137M	0.16%	116
2024 Q1	$420M	Buy	4,399,451 +406,989	+10%	+$34.2M	0.15%	135
2023 Q4	$304M	Buy	3,992,462 +130,458	+3%	+$9.08M	0.12%	171
2023 Q3	$268M	Sell	3,862,004 -82,832	-2%	-$6.66M	0.12%	172
2023 Q2	$326M	Hold	3,944,836	–	–	0.16%	132
2023 Q1	$326M	Buy	3,944,836 +185,662	+5%	+$14.6M	0.16%	132
2022 Q4	$280M	Buy	3,759,174 +72,201	+2%	+$5.56M	0.15%	163
2022 Q3	$305M	Sell	3,686,973 -904,201	-20%	-$87M	0.17%	127
2022 Q2	$437M	Sell	4,591,174 -263,361	-5%	-$27.3M	0.23%	84
2022 Q1	$571M	Sell	4,854,535 -1,745,067	-26%	-$196M	0.24%	81
2021 Q4	$855M	Buy	6,599,602 +2,198,164	+50%	+$256M	0.33%	59
2021 Q3	$498M	Buy	4,401,438 +93,674	+2%	+$10.7M	0.21%	106
2021 Q2	$446M	Buy	4,307,764 +672,520	+18%	+$63.4M	0.19%	111
2021 Q1	$304M	Sell	3,635,244 -914,799	-20%	-$77.3M	0.13%	159
2020 Q4	$415M	Sell	4,550,043 -1,207,794	-21%	-$100M	0.19%	105
2020 Q3	$460M	Buy	5,757,837 +524,179	+10%	+$40.9M	0.25%	82
2020 Q2	$362M	Buy	5,233,658 +63,053	+1%	+$4.48M	0.22%	90
2020 Q1	$325M	Buy	5,170,605 +385,848	+8%	+$27.8M	0.23%	85
2019 Q4	$372M	Buy	4,784,757 +1,259,940	+36%	+$98.4M	0.23%	85
2019 Q3	$258M	Buy	3,524,817 +723,978	+26%	+$50.9M	0.17%	117
2019 Q2	$172M	Buy	2,800,839 +221,559	+9%	+$13.4M	0.12%	183
2019 Q1	$164M	Buy	2,579,280 +218,124	+9%	+$12.4M	0.12%	191
2018 Q4	$121M	Buy	2,361,156 +129,888	+6%	+$6.57M	0.1%	218
2018 Q3	$129M	Sell	2,231,268 -3,483	-0.2%	-$170K	0.1%	233
2018 Q2	$108M	Buy	2,234,751 +21,738	+1%	+$1.01M	0.08%	278
2018 Q1	$103M	Buy	2,213,013 +275,427	+14%	+$12M	0.08%	284
2017 Q4	$72.8M	Buy	1,937,586 +80,907	+4%	+$2.97M	0.06%	340
2017 Q3	$67.7M	Buy	1,856,679 +23,493	+1%	+$896K	0.06%	336
2017 Q2	$72.3M	Buy	1,833,186 +110,808	+6%	+$4.04M	0.07%	306
2017 Q1	$54M	Buy	1,722,378 +124,908	+8%	+$3.91M	0.06%	375
2016 Q4	$49.9M	Sell	1,597,470 -52,956	-3%	-$1.72M	0.06%	370
2016 Q3	$66.3M	Buy	1,650,426 +57,216	+4%	+$2.15M	0.07%	300
2016 Q2	$53M	Sell	1,593,210 -12,066	-0.8%	-$413K	0.06%	348
2016 Q1	$47.2M	Buy	1,605,276 +13,089	+0.8%	+$361K	0.05%	372
2015 Q4	$41.9M	Sell	1,592,187 -334,287	-17%	-$8.68M	0.05%	412
2015 Q3	$45.6M	Sell	1,926,474 -1,233,246	-39%	-$29.8M	0.05%	403
2015 Q2	$75M	Sell	3,159,720 -84,330	-3%	-$1.9M	0.07%	298
2015 Q1	$77M	Sell	3,244,050 -84,414	-3%	-$1.89M	0.07%	289
2014 Q4	$70.7M	Sell	3,328,464 -499,800	-13%	-$10M	0.07%	311
2014 Q3	$65.2M	Buy	3,828,264 +899,916	+31%	+$14.2M	0.06%	318
2014 Q2	$41.9M	Buy	2,928,348 +184,302	+7%	+$2.5M	0.04%	463
2014 Q1	$33.9M	Buy	2,744,046 +202,116	+8%	+$2.33M	0.04%	503
2013 Q4	$27.9M	Buy	2,541,930 +211,218	+9%	+$2.38M	0.03%	535
2013 Q3	$27M	Buy	2,330,712 +421,830	+22%	+$4.94M	0.03%	510
2013 Q2	$21.4M	Buy	+1,908,882	New	+$22.6M	0.03%	552